Sentinel lymph node biopsy in gastric cancer

Area of Science:

• Oncology
• Surgical Innovation
• Medical Imaging

Background:

• Sentinel lymph node (SLN) mapping for early-stage gastric cancer remains a debated topic.
• Recent studies, including meta-analyses and prospective trials, indicate promising SLN detection rates and accuracy.

Purpose of the Study:

• To evaluate the current status and future potential of SLN mapping in early-stage gastric cancer.
• To explore advancements in SLN mapping technologies and their impact on treatment strategies.

Main Methods:

• Review of recent meta-analyses and prospective multicenter trials on SLN mapping.
• Discussion of traditional dual-tracer methods (radioactive colloids and blue dyes).
• Exploration of emerging technologies like indocyanine green (ICG) infrared and fluorescence imaging.

Main Results:

• Acceptable SLN detection rates and accurate lymph node status determination have been demonstrated.
• The dual-tracer method is currently the most reliable for stable SLN detection.
• New technologies like ICG imaging show potential to revolutionize SLN mapping.

Conclusions:

• SLN mapping is a viable approach for staging early-stage gastric cancer.
• Advancements in imaging technologies promise to enhance SLN mapping efficacy.
• Individualized, minimally invasive treatments based on SLN concept can improve patient quality of life.